fda semaglutide compounding enforcement october 2025 Troubling Findings in Study of GLP-1 Compounders FDA Warns on Certain Forms

The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy

The ~60% reduction in oral contraceptive absorption was specifically documented with tirzepatide

Thank you Travis, Tanya and Sandra

Tracking how you feel after each dose helps you and your healthcare provider make informed decisions about dose adjustments

Tell your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting

Common Side Effects of GLP-1 Medications Like any medication, GLP-1 treatments may cause side effects, which is why a real-time medical consultation, and ongoing monitoring by experienced doctors, are needed to ensure they are appropriately prescribed